Mainz Biomed Reports Positive Results from Feasibility Study Evaluating its Portfolio of Novel mRNA
Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous29.03.2023 / 09:01 CET/CESTThe issuer is solely responsible for the content of this announcement.Mainz Biomed Reports Positive Results from Feasibility Study Evaluating its Portfolio of Novel mRNA Biomarkers for Early Detection of Advanced Colorectal Adenomas Mai...
United States Melissa Laverty Valerie Anne Hennecke Caroline Bergmann Guido Baechler Mainz Biomed Us Preventive Services Task
Source: pharmiweb.com